期刊
BLOOD
卷 113, 期 26, 页码 6707-6715出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2008-09-178095
关键词
-
类别
资金
- Anti-Doping Denmark
- Secretariat d'Etat aux Sports, a la Jeunesse et a la Vie Associative (Direction des Sports)
- Telethon Italy [GGP06213]
- Cariverona Foundation (Verona, Italy)
- Associazione Everest-K2-CNR and Fondo per gli Investimenti della Ricerca di Base RBRN07BMCT
- Italian University and Scientific Research Ministry (MIUR)
The high iron demand associated with enhanced erythropoiesis during high-altitude hypoxia leads to skeletal muscle iron mobilization and decrease in myoglobin protein levels. To investigate the effect of enhanced erythropoiesis on systemic and muscle iron metabolism under nonhypoxic conditions, 8 healthy volunteers were treated with recombinant erythropoietin (rhEpo) for 1 month. As expected, the treatment efficiently increased erythropoiesis and stimulated bone marrow iron use. It was also associated with a prompt and considerable decrease in urinary hepcidin and a slight transient increase in GDF-15. The increased iron use and reduced hepcidin levels suggested increased iron mobilization, but the treatment was associated with increased muscle iron and L ferritin levels. The muscle expression of transferrin receptor and ferroportin was upregulated by rhEpo administration, whereas no appreciable change in myoglobin levels was observed, which suggests unaltered muscle oxygen homeostasis. In conclusion, under rhEpo stimulation, the changes in the expression of muscle iron proteins indicate the occurrence of skeletal muscle iron accumulation despite the remarkable hepcidin suppression that may be mediated by several factors, such as rhEpo or decreased transferrin saturation or both. (Blood. 2009;113:6707-6715)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据